全关节置换术后贫血患者静脉血栓栓塞风险增加:输血是罪魁祸首吗?
基于Premier医疗数据库2015年1月至2020年12月1,290,815例初次择期全髋或全膝关节置换成人患者,比较无贫血未输血对照组、贫血未输血组和贫血输血组。校正混杂后,贫血未输血组与对照组深静脉血栓、肺栓塞和静脉血栓栓塞风险无差异;贫血输血组肺栓塞(校正OR 1.83)和静脉血栓栓塞(校正OR 1.39)风险较对照组增加。
要点
- 贫血未输血组与对照组相比,深静脉血栓、肺栓塞和静脉血栓栓塞风险无显著差异。
- 贫血输血组肺栓塞校正OR 1.83(95%CI 1.34-2.51),静脉血栓栓塞校正OR 1.39(95%CI 1.14-1.70)。
- 骨科医生需意识到输血风险,并个体化使用输血。
核心结论
- 接受输血的急性失血性贫血患者在全关节置换术后发生静脉血栓栓塞的风险增加,而未接受输血的贫血患者风险未增加。
- 骨科医生需要意识到输血的风险,并对患者个体化使用输血。
研究设计与样本
- 使用国际疾病分类第十版(ICD-10)和现行操作术语(CPT)编码查询Premier医疗数据库,纳入2015年1月至2020年12月所有接受初次择期全髋关节置换术或全膝关节置换术的成人。
- 患者分为3组:无贫血诊断且未接受红细胞输注的对照组、急性失血性贫血未输血组、急性失血性贫血接受输血组;主要结局为90天深静脉血栓、肺栓塞和静脉血栓栓塞发生率及风险。
- 采用方差分析和两两比较进行组间比较,并进行多因素分析以校正混杂因素;证据等级为预后III级。
主要发现
- 共纳入1,290,815例全关节置换患者,其中对照组1,078,507例(83.6%),贫血未输血组198,233例(15.4%),贫血输血组14,075例(1.1%)。
- 三组在年龄、性别、种族、住院时间和住院费用方面差异显著。
- 校正混杂因素后,贫血未输血组与对照组相比,深静脉血栓(校正OR 0.97,95%CI 0.89-1.06,p=0.500)、肺栓塞(校正OR 1.04,95%CI 0.92-1.18,p=0.543)和静脉血栓栓塞(校正OR 0.99,95%CI 0.92-1.06,p=0.697)风险无差异。
- 与对照组相比,贫血输血组肺栓塞风险增加(校正OR 1.83,95%CI 1.34-2.51,p<0.001),静脉血栓栓塞风险增加(校正OR 1.39,95%CI 1.14-1.70,p=0.001)。
关键数值与推荐
- 贫血未输血组 vs 对照组:深静脉血栓校正OR 0.97(95%CI 0.89-1.06,p=0.500),肺栓塞校正OR 1.04(95%CI 0.92-1.18,p=0.543),静脉血栓栓塞校正OR 0.99(95%CI 0.92-1.06,p=0.697)。
- 贫血输血组 vs 对照组:肺栓塞校正OR 1.83(95%CI 1.34-2.51,p<0.001),静脉血栓栓塞校正OR 1.39(95%CI 1.14-1.70,p=0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The relationship between anemia and the risk of venous thromboembolism (VTE) following total knee arthroplasty (TKA) and total hip arthroplasty (THA) remains unclear. Red blood cell (RBC) transfusions, which have been shown to have thrombogenic effects, may explain conflicting data. This study sought to elucidate the relationship between anemia, RBC transfusions, and VTE following total joint arthroplasty (TJA). METHODS: Using the International Classification of Diseases, Tenth Revision (ICD-10) and Current Procedural Terminology (CPT) codes, the Premier Healthcare Database was queried for all adults who underwent primary elective THA or TKA from January 2015 to December 2020. Patients were classified into 3 cohorts: those who did not have a diagnosis of anemia and did not receive an RBC transfusion (the control group), those with acute blood loss anemia who did not receive a transfusion (the anemia without transfusion group), and those with acute blood loss anemia who did receive a transfusion (the anemia with transfusion group). The primary outcomes assessed were the 90-day rate and risk of deep vein thrombosis (DVT), pulmonary embolism (PE), and aggregate VTE. Analysis of variance and pairwise comparisons were used to compare groups. Multivariable analyses were performed to account for confounding factors. RESULTS: The 1,290,815 patients identified as having undergone TJA included 1,078,507 control patients (83.6%), 198,233 patients who had anemia without transfusion (15.4%), and 14,075 patients who had anemia and transfusion (1.1%). Age, sex, race, length of hospital stay, and hospital costs were significantly different between the 3 groups. After adjusting for confounding factors, there was no difference between the anemia without transfusion group and the control group with regard to DVT (adjusted odds ratio [OR], 0.97 [95% confidence interval (CI), 0.89 to 1.06]; p = 0.500), PE (adjusted OR, 1.04 [95% CI, 0.92 to 1.18]; p = 0.543), and VTE (adjusted OR, 0.99 [95% CI, 0.92 to 1.06]; p = 0.697). However, patients with anemia and transfusion had an increased risk of PE (adjusted OR, 1.83 [95% CI, 1.34 to 2.51]; p < 0.001) and VTE (adjusted OR, 1.39 [95% CI, 1.14 to 1.70]; p = 0.001) compared with patients in the control group. CONCLUSIONS: Patients with acute blood loss anemia who received a transfusion were at increased risk for developing VTE following TJA, whereas patients with anemia who did not receive a transfusion were not. Orthopaedic surgeons need to be aware of the risks of transfusion and individualize the use of transfusions in their patients. LEVEL OF EVIDENCE: Prognostic Level III . See Instructions for Authors for a complete description of levels of evidence.
引用
- Liu KC, Piple AS, Richardson MK, et al. Increased Risk of Venous Thromboembolism in Patients with Postoperative Anemia After Total Joint Arthroplasty: Are Transfusions to Blame? J Bone Joint Surg Am. 2023. PMID: 37471565. doi:10.2106/JBJS.23.00146
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。